Drug Shortage Report for IRBESARTAN
Report ID | 126591 |
Drug Identification Number | 02385287 |
Brand name | IRBESARTAN |
Common or Proper name | IRBESARTAN |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 75MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2020-10-12 |
Estimated end date | Unknown |
Actual end date | 2020-11-30 |
Shortage status | Resolved |
Updated date | 2021-02-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-02-12 | French | Compare |
v3 | 2021-02-12 | English | Compare |
v2 | 2020-10-16 | French | Compare |
v1 | 2020-10-16 | English | Compare |
Showing 1 to 4 of 4